Summary by Moomoo AI
MicroChung Medical Sciences Limited updated its annual results forecast for the year ended December 31, 2023 on March 22, 2024. The company expects a loss during the reporting period of no more than $650 million. This update is based on an initial assessment made by the Company after further evaluation and has not been reviewed or reviewed by an independent auditor or audit committee. Micro-CHO reminds shareholders and potential investors that the announcement of its full annual results will be released by the end of March 2024 and advises to exercise caution when trading the company's shares and securities.